Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 84

Sort by

Sort Order Select

Journal Articles

Preliminary Phase 1 Data on the Safety and Efficacy of a Novel PET Radiotracer, 124 I-p5+14, for Imaging Systemic Amyloidosis

Blood (2019) 134 (Supplement_1): 3034.

https://doi.org/10.1182/blood-2019-128850

Published: 2019

Journal Articles

Identification of Genetic Vulnerabilities and Synthetic-Lethal Targets in NSD2-High Multiple Myeloma

Amin Sobh, PhD, Charlotte Kaestner, Alberto Riva, PhD, Jonathan D. Licht, MD

Blood (2019) 134 (Supplement_1): 3757.

https://doi.org/10.1182/blood-2019-125951

Published: 2019

Journal Articles

Antithrombin- and Heparin-Binding Exosites Regulate Extravascular Binding and Clearance of Factor IXa

Pamela Westmark, PhD, John P. Sheehan, MD

Blood (2019) 134 (Supplement_1): 2392.

https://doi.org/10.1182/blood-2019-131580

Published: 2019

Journal Articles

Hemostatic Activation and Glycocalyx Shedding during Pregnancy

Maria Cristina Bravo, PhD, Ira Bernstein, MD, Carole McBride, PhD, Elizabeth McGee, MD, Kelley C. McLean, MD, Thomas Orfeo, PhD, Kathleen E. Brummel-Ziedins, PhD

Blood (2018) 132 (Supplement 1): 3794.

https://doi.org/10.1182/blood-2018-99-119304

Published: 2018

Journal Articles

Distinct Effects of Chondroitin Sulfate on Hematopoietic Cells and the Stromal Microenvironment in Bone Marrow Hematopoiesis

Takayuki Katagiri, MD, Takashi Ushiki, MD PhD, Asami Kawasaki, PhD, Shun Uemura, MD, Tatsuya Suwabe, MD, Tomoyuki Tanaka, MD PhD, Kyoko Fuse, MD, Yasuhiko Shibasaki, MD, Hirohito Sone, MD PhD, Michihiro Igarashi, MD PhD, Masayoshi Masuko, MD PhD

Blood (2018) 132 (Supplement 1): 3852.

https://doi.org/10.1182/blood-2018-99-115796

Published: 2018

Journal Articles

Tissue Factor Pathway Inhibitor Enhances Transendothelial Migration of Chronic Lymphocytic Leukemia Cells through Binding to Glypican-3

Xueyan Cui, MD PhD, Geir Erland Tjønnfjord, MD DMsc, Sandip Kanse, PhD, Nina Iversen, PhD, Anders EA Dahm, MD PhD, Christiane Filion Myklebust, Ling Sun, MD PhD, Zhong Xing Jiang, MD PhD, Mitchell Ho, PhD, Per Morten Sandset

Blood (2018) 132 (Supplement 1): 2452.

https://doi.org/10.1182/blood-2018-99-111241

Published: 2018

Journal Articles

Role of Protease Exosites for In Vivo Hemostatic Activity and Clearance of FIX

Pamela Westmark, PhD, John Sheehan, MD

Blood (2018) 132 (Supplement 1): 1166.

https://doi.org/10.1182/blood-2018-99-120212

Published: 2018

Journal Articles

Syndecan-1 promotes Wnt/β-catenin signaling in multiple myeloma by presenting Wnts and R-spondins

Zemin Ren, Harmen van Andel, Wim de Lau, Robin B. Hartholt, Madelon M. Maurice, Hans Clevers, Marie José Kersten, Marcel Spaargaren, Steven T. Pals

Blood (2018) 131 (9): 982–994.

https://doi.org/10.1182/blood-2017-07-797050

Published: 2018

Includes: Supplemental data

Journal Articles

Functional rs4693608 SNP is Located into Strong Hpse Gene Intron Enhancer and Thereby Influences to the Ability of Nuclear Proteins Binding and Activity of This Enhancer in Broad Number of Hematological Cell Lines and ALL/AML Primary Samples

Olga Ostrovsky, PhD, Ania Hava Grushchenko Polaq, Katia Beider, PhD, Rita Mayorov, Avichai Shimoni, MD, Israel Vlodavsky, PhD, Arnon Nagler

Blood (2016) 128 (22): 3934.

https://doi.org/10.1182/blood.V128.22.3934.3934

Published: 2016

Journal Articles

EPCR Guides Hematopoietic Stem Cells Homing to the Bone Marrow Independently of Niche Clearance

Blood (2016) 128 (22): 4538.

https://doi.org/10.1182/blood.V128.22.4538.4538

Published: 2016

Journal Articles

CD138 Regulates Myeloma Cell Survival, Proliferation, BM Engraftment and Tumor Organization

David R Fooksman, PhD, Amitabha Mazumder, MD, Mark McCarron, PhD

Blood (2015) 126 (23): 2974.

https://doi.org/10.1182/blood.V126.23.2974.2974

Published: 2015

Journal Articles

Membrane Remodeling By Pathogenic Antibodies Underlies Monocyte Activation in Heparin-Induced Thrombocytopenia

Izabella Andrianova, Vincent M Hayes, BS, Daria Madeeva, MD, Rustem I. Litvinov, PhD, Douglas B. Cines, MD, Mortimer Poncz, MD, John W. Weisel, PhD, Lubica Rauova, MD PhD

Blood (2015) 126 (23): 2244.

https://doi.org/10.1182/blood.V126.23.2244.2244

Published: 2015

Journal Articles

Roneparstat (SST0001), an Innovative Heparanase (HPSE) Inhibitor for Multiple Myeloma (MM) Therapy: First in Man Study

Monica Galli, MD, Hila Magen, MD, Hermann Einsele, Manik Chatterjee, MD, Mariella Grasso, MD, Giorgina Specchia, Paola Barbieri, MD, David Paoletti, MS, Silvia Pace, MS, Ralph D Sanderson, PhD, Alessandro Rambaldi, MD, Arnon Nagler, MD MSc

Blood (2015) 126 (23): 3246.

https://doi.org/10.1182/blood.V126.23.3246.3246

Published: 2015

Journal Articles

Heparanase Promotes Myeloma Metastasis By Inducing EMT-like Features in Both Myeloma Cells and Endothelial Cells

Qianying Pan, MD, Patrick D Rowan, BS, Racquel Innis-Shelton, MD, Timothy N Trotter, BS, Mei Li, PhD, Deniz Peker, MD, Larry J Suva, PhD, Yang Yang, MD PhD

Blood (2014) 124 (21): 2025.

https://doi.org/10.1182/blood.V124.21.2025.2025

Published: 2014

Journal Articles

New Insights into the Prothrombotic State of Heparin-Induced Thrombocytopenia (HIT) Using a Novel Microfluidic System: The Endothelial Lining and “Rolling Barrage” of Activation

Vincent Hayes, Ian Johnston, BS, Douglas B. Cines, MD, Lubica Rauova, MD PhD, Mortimer Poncz, MD

Blood (2014) 124 (21): 574.

https://doi.org/10.1182/blood.V124.21.574.574

Published: 2014

Journal Articles

Heparanase Polymorphisms: Influence on Incidence of Hepatic Sinusoidal Obstruction Syndrome in Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Bernd Gruhn, MD, Susan Wittig, Clemens Arndt, Claudia Seifert

Blood (2014) 124 (21): 3886.

https://doi.org/10.1182/blood.V124.21.3886.3886

Published: 2014

Journal Articles

Inhibiting stromal cell heparan sulfate synthesis improves stem cell mobilization and enables engraftment without cytotoxic conditioning

Blood (2014) 124 (19): 2937–2947.

https://doi.org/10.1182/blood-2014-08-593426

Published: 2014

Includes: Supplemental data

Journal Articles

Heparan sulfate: a stem cell therapy target?

Timothy S. Olson

Blood (2014) 124 (19): 2895–2896.

https://doi.org/10.1182/blood-2014-09-601401

Published: 2014

Journal Articles

Effect Of Combined Heparin- and Antithrombin-Binding Exosite Mutations On Human Factor IX(a) Coagulant Activity, Thrombin Generation, and Protease Half-Life In Human Plasma

Pamela R. Westmark, Ph.D., Pansakorn Tanratana, M.D., John P. Sheehan, MD

Blood (2013) 122 (21): 2333.

https://doi.org/10.1182/blood.V122.21.2333.2333

Published: 2013

Journal Articles

Heparanase Expression Correlates with Bone Destruction in the Patients with Multiple Myeloma

Shi Wei, MD, Racquel Innis-Shelton, MD, Li Nan, Jian Ruan, MD, Rebecca S Sollie, Vishnu V B Reddy, MD, Yang Yang, MD, PhD

Blood (2012) 120 (21): 1813.

https://doi.org/10.1182/blood.V120.21.1813.1813

Published: 2012

NARROW

Preliminary Phase 1 Data on the Safety and Efficacy of a Novel PET Radiotracer, 124 I-p5+14, for Imaging Systemic Amyloidosis

Identification of Genetic Vulnerabilities and Synthetic-Lethal Targets in NSD2-High Multiple Myeloma

Antithrombin- and Heparin-Binding Exosites Regulate Extravascular Binding and Clearance of Factor IXa

Hemostatic Activation and Glycocalyx Shedding during Pregnancy

Distinct Effects of Chondroitin Sulfate on Hematopoietic Cells and the Stromal Microenvironment in Bone Marrow Hematopoiesis

Tissue Factor Pathway Inhibitor Enhances Transendothelial Migration of Chronic Lymphocytic Leukemia Cells through Binding to Glypican-3

Role of Protease Exosites for In Vivo Hemostatic Activity and Clearance of FIX

Syndecan-1 promotes Wnt/β-catenin signaling in multiple myeloma by presenting Wnts and R-spondins

Functional rs4693608 SNP is Located into Strong Hpse Gene Intron Enhancer and Thereby Influences to the Ability of Nuclear Proteins Binding and Activity of This Enhancer in Broad Number of Hematological Cell Lines and ALL/AML Primary Samples

EPCR Guides Hematopoietic Stem Cells Homing to the Bone Marrow Independently of Niche Clearance

CD138 Regulates Myeloma Cell Survival, Proliferation, BM Engraftment and Tumor Organization

Membrane Remodeling By Pathogenic Antibodies Underlies Monocyte Activation in Heparin-Induced Thrombocytopenia

Roneparstat (SST0001), an Innovative Heparanase (HPSE) Inhibitor for Multiple Myeloma (MM) Therapy: First in Man Study

Heparanase Promotes Myeloma Metastasis By Inducing EMT-like Features in Both Myeloma Cells and Endothelial Cells

New Insights into the Prothrombotic State of Heparin-Induced Thrombocytopenia (HIT) Using a Novel Microfluidic System: The Endothelial Lining and “Rolling Barrage” of Activation

Heparanase Polymorphisms: Influence on Incidence of Hepatic Sinusoidal Obstruction Syndrome in Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Inhibiting stromal cell heparan sulfate synthesis improves stem cell mobilization and enables engraftment without cytotoxic conditioning

Heparan sulfate: a stem cell therapy target?

Effect Of Combined Heparin- and Antithrombin-Binding Exosite Mutations On Human Factor IX(a) Coagulant Activity, Thrombin Generation, and Protease Half-Life In Human Plasma

Heparanase Expression Correlates with Bone Destruction in the Patients with Multiple Myeloma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only